NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon. | Antimicrob Agents Chemother;50(9): 2976-82, 2006 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon.

Ma, Sue; Boerner, Joanna E; TiongYip, ChoiLai; Weidmann, Beat; Ryder, Neil S; Cooreman, Michael P; Lin, Kai.

Affiliation

Ma S; Novartis Institutes for Biomedical Research, Inc., 500 Technology Square, Cambridge, MA 02139, USA.

Antimicrob Agents Chemother ; 50(9): 2976-82, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16940091

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Interferon-alpha / Cyclosporine / Hepacivirus / Cyclophilins Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2006 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Interferon-alpha / Cyclosporine / Hepacivirus / Cyclophilins Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2006 Document type: Article Affiliation country: